Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4476
Lifetime Brands
LCUT
$210M
| $92.5K | ﹤0.01% |
18,141
-12,564
| -41% | -$46.7K |
2023 Q3
7 quarters
|
|
4477
Open Text
OTEX
$5.38B
| $92.2K | ﹤0.01% |
3,159
+3,094
| +4,760% | +$84.1K |
2013 Q2
48 quarters
|
|
4478
Duluth Holdings
DLTH
$149M
| $92.2K | ﹤0.01% |
43,907
-1,992
| -4% | -$3.74K |
2015 Q4
38 quarters
|
|
4479
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.9B
| $91.9K | ﹤0.01% |
2,736
| – | – |
2023 Q2
8 quarters
|
|
|
FEBM
4480
FT Vest U.S. Equity Max Buffer ETF - February
FEBM
$46.1M
| $91.8K | ﹤0.01% |
+3,132
| New | +$90.1K |
2025 Q2
0 quarters
|
|
4481
Adicet Bio
ACET
$60.8M
| $91.5K | ﹤0.01% |
+9,375
| New | +$98.9K |
2025 Q2
0 quarters
|
|
|
NXXT
4482
NextNRG Inc
NXXT
$12.5M
| $91K | ﹤0.01% |
3,284
+3,272
| +27,267% | +$99.9K |
2025 Q1
1 quarter
|
|
4483
GoPro
GPRO
$279M
| $90.9K | ﹤0.01% |
119,974
-129,735
| -52% | -$84.3K |
2014 Q3
43 quarters
|
|
4484
Polestar Automotive Holding UK
PSNY
$1.02B
| $90.5K | ﹤0.01% |
2,819
-92
| -3% | -$2.92K |
2024 Q4
2 quarters
|
|
4485
Innovator US Equity Buffer ETF May
BMAY
$239M
| $90.1K | ﹤0.01% |
2,134
-1,451
| -40% | -$58.1K |
2024 Q3
3 quarters
|
|
|
NOAH
4486
Noah Holdings
NOAH
$535M
| $90.1K | ﹤0.01% |
7,542
+1,018
| +16% | +$10.3K |
2018 Q2
28 quarters
|
|
4487
Gildan
GIL
$7.59B
| $89.9K | ﹤0.01% |
1,825
-4,750
| -72% | -$218K |
2017 Q2
32 quarters
|
|
4488
InfuSystem Holdings
INFU
$262M
| $89.8K | ﹤0.01% |
14,394
-14,583
| -50% | -$80.6K |
2023 Q2
8 quarters
|
|
4489
Traeger
COOK
$149M
| $89.3K | ﹤0.01% |
1,045
+349
| +50% | +$26.8K |
2022 Q1
13 quarters
|
|
4490
AllianzIM US Equity 6 Month Floor5 Jan/Jul ETF
FLJJ
$8.64M
| $89.2K | ﹤0.01% |
2,947
+2,944
| +98,133% | +$84.2K |
2025 Q1
1 quarter
|
|
4491
Beamr Imaging
BMR
$19.6M
| $88.9K | ﹤0.01% |
28,163
-32,877
| -54% | -$89.7K |
2024 Q3
3 quarters
|
|
4492
FitLife Brands
FTLF
$86.6M
| $88.7K | ﹤0.01% |
6,815
+6,219
| +1,043% | +$85.5K |
2024 Q3
3 quarters
|
|
4493
FT Vest US Equity Buffer ETF April
FAPR
$1.33B
| $88.7K | ﹤0.01% |
2,103
+2,007
| +2,091% | +$81.4K |
2024 Q3
3 quarters
|
|
|
IMA
4494
ImageneBio Inc
IMA
$52.2M
| $88.7K | ﹤0.01% |
5,515
| – | – |
2022 Q1
13 quarters
|
|
4495
iShares MSCI Europe Small-Cap ETF
IEUS
$171M
| $88.6K | ﹤0.01% |
1,320
| – | – |
2020 Q1
21 quarters
|
|
4496
FT Vest US Equity Deep Buffer ETF May
DMAY
$383M
| $88.3K | ﹤0.01% |
2,063
+199
| +11% | +$8.05K |
2024 Q3
3 quarters
|
|
4497
INmune Bio
INMB
$53.6M
| $87.7K | ﹤0.01% |
37,986
+18,144
| +91% | +$133K |
2024 Q2
4 quarters
|
|
4498
inTEST
INTT
$158M
| $86.2K | ﹤0.01% |
11,846
| – | – |
2023 Q1
9 quarters
|
|
4499
Tevogen Inc
TVGN
$45.5M
| $85.7K | ﹤0.01% |
1,372
+611
| +80% | +$34.8K |
2024 Q2
4 quarters
|
|
4500
Ispire Technology
ISPR
$79.7M
| $85.1K | ﹤0.01% |
33,250
+12,362
| +59% | +$34.4K |
2023 Q2
8 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.